BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38170953)

  • 1. Successful Autologous Hematopoietic Stem Cell Transplant in Glycine Receptor Antibody-Positive Stiff Person Syndrome: A Case Report.
    Celli SI; Nash R; Money KM; Garza M; Borko TL; Mizenko C; McMenamin C; Von Geldern G; Georges G; Piquet AL
    Neurol Neuroimmunol Neuroinflamm; 2024 Mar; 11(2):e200197. PubMed ID: 38170953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program.
    Sanders S; Bredeson C; Pringle CE; Martin L; Allan D; Bence-Bruckler I; Hamelin L; Hopkins HS; Sabloff M; Sheppard D; Tay J; Huebsch L; Atkins HL
    JAMA Neurol; 2014 Oct; 71(10):1296-9. PubMed ID: 25155372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience.
    Kass-Iliyya L; Snowden JA; Thorpe A; Jessop H; Chantry AD; Sarrigiannis PG; Hadjivassiliou M; Sharrack B
    J Neurol; 2021 Jan; 268(1):265-275. PubMed ID: 32785838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, Clinical Profiles, and Prognosis of Stiff-Person Syndrome in a Japanese Nationwide Survey.
    Matsui N; Tanaka K; Ishida M; Yamamoto Y; Matsubara Y; Saika R; Iizuka T; Nakamura K; Kuriyama N; Matsui M; Arisawa K; Nakamura Y; Kaji R; Kuwabara S; Izumi Y;
    Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37739810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.
    Martinez-Hernandez E; Ariño H; McKeon A; Iizuka T; Titulaer MJ; Simabukuro MM; Lancaster E; Petit-Pedrol M; Planagumà J; Blanco Y; Harvey RJ; Saiz A; Graus F; Dalmau J
    JAMA Neurol; 2016 Jun; 73(6):714-20. PubMed ID: 27065452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial.
    Burt RK; Balabanov R; Han X; Quigley K; Arnautovic I; Helenowski I; Rose J; Siddique T
    Neurology; 2021 Feb; 96(6):e817-e830. PubMed ID: 33318163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stiff-person syndrome associated with multiple myeloma following autologous bone marrow transplantation.
    Clow EC; Couban S; Grant IA
    Muscle Nerve; 2008 Dec; 38(6):1649-52. PubMed ID: 18932204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous hematopoietic stem cells for refractory Crohn's disease.
    DiNicola CA; Zand A; Hommes DW
    Expert Opin Biol Ther; 2017 May; 17(5):555-564. PubMed ID: 28326848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited Benefits Halt Enrollment in Hematopoietic Stem Cell Transplantation Trial for Stiff-Person Syndrome: Should There Be More to Come?
    Dalakas MC
    Neurology; 2021 Feb; 96(6):239-240. PubMed ID: 33318165
    [No Abstract]   [Full Text] [Related]  

  • 10. Stiff person spectrum disorders: An illustrative case series of their phenotypic and antibody diversity.
    Bernardo F; Rebordão L; Rêgo A; Machado S; Passos J; Costa C; Cruz S; Pinto AN; Santos M
    J Neuroimmunol; 2020 Apr; 341():577192. PubMed ID: 32087460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
    Muraro PA; Pasquini M; Atkins HL; Bowen JD; Farge D; Fassas A; Freedman MS; Georges GE; Gualandi F; Hamerschlak N; Havrdova E; Kimiskidis VK; Kozak T; Mancardi GL; Massacesi L; Moraes DA; Nash RA; Pavletic S; Ouyang J; Rovira M; Saiz A; Simoes B; Trnený M; Zhu L; Badoglio M; Zhong X; Sormani MP; Saccardi R;
    JAMA Neurol; 2017 Apr; 74(4):459-469. PubMed ID: 28241268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
    Lemieux C; Ahmad I; Bambace NM; Bernard L; Cohen S; Delisle JS; Fleury I; Kiss T; Mollica L; Roy DC; Sauvageau G; Roy J; Lachance S
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):157-161. PubMed ID: 31521818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis.
    Revannasiddaiah S; Nagaraju PRVMA; Palassery R; Jagadish A; Maka VV; Kilara N; Rondelli D; Devadas SK
    J Egypt Natl Canc Inst; 2022 May; 34(1):21. PubMed ID: 35570260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation in highly active multiple sclerosis.
    Giedraitiene N; Kizlaitiene R; Peceliunas V; Griskevicius L; Kaubrys G
    Sci Rep; 2020 Dec; 10(1):21286. PubMed ID: 33277590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
    Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation for uncommon immune-mediated neurological disorders: A literature review.
    Jaime-Pérez JC; Meléndez-Flores JD; Ramos-Dávila EM; González-Treviño M; Gómez-Almaguer D
    Cytotherapy; 2022 Jul; 24(7):676-685. PubMed ID: 35193829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity.
    Harris KM; Lu T; Lim N; Turka LA
    Front Immunol; 2018; 9():100. PubMed ID: 29456529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous hematopoietic stem-cell transplantation in neurological disorders: current approach and future directions.
    Das J; Sharrack B; Snowden JA
    Expert Rev Neurother; 2020 Dec; 20(12):1299-1313. PubMed ID: 32893698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
    Casanova B; Jarque I; Gascón F; Hernández-Boluda JC; Pérez-Miralles F; de la Rubia J; Alcalá C; Sanz J; Mallada J; Cervelló A; Navarré A; Carcelén-Gadea M; Boscá I; Gil-Perotin S; Solano C; Sanz MA; Coret F
    Neurol Sci; 2017 Jul; 38(7):1213-1221. PubMed ID: 28396953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.